IntelGenx Technologies Stock Price (OTCMKTS:IGXT)

Add to My Stocks
$1.21 $0.62 (33.88%) IGXT stock closing price Sep 21, 2018 (Closing)
Prev Close* : $1.83
Market Cap:
$85.9M
Day Low: $1.18
52 Week Low: $0.60
Open: $1.67
Volume: -
Day High: $1.8
52 Week High: $1.83
Dividend:
0.00

Latest Stock Market News

Latest Articles

IGXT Stockcharts

View IGXT PE ratio, PS ratio stocks charts and compare with peers.
IGXT Chart
Note: Compare IntelGenx Technologies stock price history with the index and industry peers.

IntelGenx Technologies Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
25.88
PB ratio (
price to book ratio
)
23.98

IntelGenx Technologies Returns

ROE
(return on equity)
-188%

IntelGenx Technologies Financial Ratios

Asset Turnover
0.08
Receivables Turnover
3.83
Debt to Equity
4.98
Dividend Yield
0%

IGXT Industry Peers

Company Price Change (%)
Biocardia Inc (BCDA)2.350.35 (17.5%)
Pharmacyte Biotech (PMCB)0.050 (0%)
Foamix (FOMX)5.970.06 (1.02%)
Alnylam Pharma (ALNY)94.570.64 (0.67%)
Skinvisible (SKVI)0.030 (0%)
Ascendis Pharma (ASND)66.51 (1.48%)
Arrowhead Pharma (ARWR)17.771.11 (5.88%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
SIGA Technologies (SIGA)7.230.48 (7.11%)
AcelRx Pharma (ACRX)3.950.25 (6.76%)
ChemoCentryx (CCXI)12.910.54 (4.37%)
Infinity Pharma (INFI)2.40.09 (3.9%)
Redhill Biopharma (RDHL)8.040.14 (1.77%)
Adamis Pharma (ADMP)3.10.05 (1.64%)
BioSpecifics Technologies (BSTC)58.520.78 (1.35%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Lannett Co (LCI)50.5 (9.09%)
Neptune Tech. & Bio. (NEPT)4.340.38 (8.05%)
Tetraphase Pharmaceuticals (TTPH)2.920.24 (7.59%)
CORREVIO PHARMA (CORV)4.020.27 (6.29%)
Arrowhead Pharma (ARWR)17.771.11 (5.88%)
Galectin Therapeutics (GALT)6.530.4 (5.77%)
Esperion Therapeutics (ESPR)43.162.59 (5.66%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

IntelGenx Technologies Corp. Stock News - Partner Headlines

IntelGenx Technologies Financial Statements

income statement20172016201520142013
Net Sales or Revenues5.19M5.22M5.09M1.65M-
Net Income-3.05M-1.18M1.29M-1.74M-1.63M
Total Operating Expense6.57M5.36M3.1M3.36M1.95M
View IntelGenx Technologies income statement
balance sheet20172016201520142013
Total Assets13.14M12.79M8.91M6.28M6.21M
Total Liabilities9.31M7.84M3.35M1.71M1.2M
Shareholders Equity3.82M4.94M5.56M4.57M5M
View IntelGenx Technologies balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-2.5M2.2M-1.04M--
Net Cash from (used by) Operating Activities-4.38M1.72M--1.38M-1.17M
Increase (Decrease) in Prop Plant And Equipment-0.97M-2.32M-3.38M-0.4M-0.26M
View IntelGenx Technologies cash flow statement

IntelGenx Technologies Stock Message Board

An investor needs to spend $1.21 to buy IGXT stock, as the closing IntelGenx Technologies stock price is $1.21. IntelGenx Technologies market capitalization is $85.9M and it represents the total market value of IGXT stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing IntelGenx Technologies stock analysis.

For recognizing and analyzing the real performance of IntelGenx Technologies stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 7,947,118 shares were traded with a closing stock price of $1.21 as of Sep 21, 2018, as can be seen from IntelGenx Technologies stock quote. One can view IntelGenx Technologies stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. IntelGenx Technologies stock dividend was 0.00 during the last quarter. IntelGenx Technologies stock price history, gives the entire historical data for IGXT stock.